Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Account Payables: 2010-2025

Historic Change in Account Payables for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to -$1.2 million.

  • Mesa Laboratories' Change in Account Payables fell 707.54% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 217.14%. This contributed to the annual value of -$388,000 for FY2025, which is 300.00% down from last year.
  • As of Q3 2025, Mesa Laboratories' Change in Account Payables stood at -$1.2 million, which was down 670.28% from $212,000 recorded in Q2 2025.
  • Mesa Laboratories' 5-year Change in Account Payables high stood at $1.6 million for Q1 2024, and its period low was -$1.7 million during Q4 2024.
  • In the last 3 years, Mesa Laboratories' Change in Account Payables had a median value of -$349,000 in 2023 and averaged -$153,455.
  • As far as peak fluctuations go, Mesa Laboratories' Change in Account Payables spiked by 856.80% in 2024, and later plummeted by 707.54% in 2025.
  • Mesa Laboratories' Change in Account Payables (Quarterly) stood at $1.4 million in 2021, then crashed by 210.09% to -$1.6 million in 2022, then soared by 77.94% to -$349,000 in 2023, then plummeted by 395.70% to -$1.7 million in 2024, then crashed by 707.54% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, $212,000 for Q2 2025, and $1.5 million during Q1 2025.